Expert Opinion on Orphan Drugs
Published by Taylor & Francis
eISSN : 2167-8707
Abbreviation : Expert Opin. Orphan Drug
Aims & Scope
Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of rare diseases and orphan drugs.
We aim to draw a spotlight on diseases that do not have a high prevalence but have a huge impact on patients and their clinicians, through valuable and high-quality expert insights.
In a field which is ever-growing and changing, Expert Opinion on Orphan Drugs is committed to acting as a reliable beacon of guidance and support for researchers, clinicians, patients and advocacy groups in order to optimise research, development, management and quality of life of rare disease patients.
The journal strives to publish high quality reviews on all areas within rare diseases and orphan drugs.
Topics can include: diagnostics, pharmacogenomics and screening; public health and epidemiology; drug development; lead generation and discovery; early or late phase clinical trials; regulatory issues; post-marketing safety and treatment outcomes.
We also welcome solicited and unsolicited papers including Drug Evaluations - specifically reviewing the pharmacological properties, clinical potential/clinical efficacy, safety and, if applicable, HE/OR data on a particular orphan drug - as well as Original Research papers and Editorials.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.286 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 29 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 17078 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 34 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.